These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18197443)

  • 1. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.
    Kofoed K; Eugen-Olsen J; Petersen J; Larsen K; Andersen O
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):375-83. PubMed ID: 18197443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
    Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
    Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic changes in plasma levels of urokinase type plasminogen activator and urokinase type plasminogen activator receptor in patients with systemic inflammatory response syndrome].
    Wu XL; Yu L; Long D; Yang JH; Zhang YC; Geng F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):478-81. PubMed ID: 21878172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
    Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
    J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
    J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.
    Charles PE; Noel R; Massin F; Guy J; Bollaert PE; Quenot JP; Gibot S
    BMC Infect Dis; 2016 Oct; 16(1):559. PubMed ID: 27729010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor?
    Chuang CC; Hung CJ; Tsai MC; Yeh TM; Chuang YC
    Crit Care Med; 2004 Mar; 32(3):734-9. PubMed ID: 15090955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis.
    Barati M; Bashar FR; Shahrami R; Zadeh MH; Taher MT; Nojomi M
    J Crit Care; 2010 Jun; 25(2):362.e1-6. PubMed ID: 19914031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of "the Sequential Organ Failure Assessment (SOFA) score" in predicting outcome in ICU patients with SIRS.
    Acharya SP; Pradhan B; Marhatta MN
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):475-83. PubMed ID: 18604078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on plasma soluble triggering receptor expressed on myeloid cells-1 in patients with sepsis].
    Wang HX; Li ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 May; 23(5):283-5. PubMed ID: 21549065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quick Sequential Organ Failure Assessment and Systemic Inflammatory Response Syndrome Criteria as Predictors of Critical Care Intervention Among Patients With Suspected Infection.
    Moskowitz A; Patel PV; Grossestreuer AV; Chase M; Shapiro NI; Berg K; Cocchi MN; Holmberg MJ; Donnino MW;
    Crit Care Med; 2017 Nov; 45(11):1813-1819. PubMed ID: 28759474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis.
    Li L; Zhu Z; Chen J; Ouyang B; Chen M; Guan X
    Am J Med Sci; 2013 Mar; 345(3):178-84. PubMed ID: 22739556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparison of severity of illness scoring system for emergency department patients with systemic inflammatory response syndrome].
    Chen YX; Li CS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Dec; 21(12):715-8. PubMed ID: 20042135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
    Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
    J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive performance of quick Sepsis-related Organ Failure Assessment for mortality and ICU admission in patients with infection at the ED.
    Wang JY; Chen YX; Guo SB; Mei X; Yang P
    Am J Emerg Med; 2016 Sep; 34(9):1788-93. PubMed ID: 27321936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
    Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
    Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.